Mitsuru Hashiramoto
Overview
Explore the profile of Mitsuru Hashiramoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirukawa H, Hashiramoto M, Tanizawa Y, Kaku K
J Diabetes Investig
. 2018 Feb;
9(5):1119-1127.
PMID: 29406607
Aims/introduction: To assess whether intervention with oral antidiabetic drug in Japanese patients with the early stage of type 2 diabetes could provide a significant remission of the disease process. Materials...
2.
Kimura T, Kaneto H, Kanda-Kimura Y, Shimoda M, Kamei S, Anno T, et al.
Intern Med
. 2016 Jun;
55(11):1419-24.
PMID: 27250046
Objective To examine the association between glycemic control and the new onset of macroangiopathy in Japanese subjects with type 2 diabetes. Methods We examined seven-year follow-up data for 572 patients....
3.
Tawaramoto K, Kaneto H, Hashiramoto M, Kawasaki F, Tatsumi F, Shimoda M, et al.
Diabetol Metab Syndr
. 2015 Sep;
7:80.
PMID: 26388951
To evaluate the efficacy of azelnidipine and amlodipine on diabetic nephropathy and atherosclerosis, we designed a prospective and randomized controlled clinical study in type 2 diabetic patients with stable glycemic...
4.
Hirukawa H, Kaneto H, Shimoda M, Kimura T, Okauchi S, Obata A, et al.
Mol Cell Endocrinol
. 2015 Jun;
413:49-60.
PMID: 26116826
We investigated the effects of long- and short-term treatment with pioglitazone (Pio) and/or alogliptin (Alo) on β-cells in diabetic db/db mice. Six-week-old male db/db mice received Pio (25 mg/kg, oral)...
5.
Tatsumi F, Kaneto H, Hashiramoto M, Tawaramoto K, Obata A, Kimura T, et al.
Endocr J
. 2015 Jun;
62(8):741-7.
PMID: 26073866
It is known that reactive oxygen species (ROS) are involved in the development of insulin resistance as well as pancreatic β-cell dysfunction both of which are often observed in type...
6.
Case of newly onset type 1 diabetes after highly active antiretroviral therapy against HIV infection
Kamei S, Kaneto H, Hashiramoto M, Hisano Y, Tanabe A, Shimoda M, et al.
J Diabetes Investig
. 2015 May;
6(3):367-8.
PMID: 25969724
No abstract available.
7.
Kanda Y, Hashiramoto M, Shimoda M, Hamamoto S, Tawaramoto K, Kimura T, et al.
J Nutr Biochem
. 2014 Dec;
26(3):219-26.
PMID: 25488546
To assess the molecular mechanisms by which dietary restriction preserves the β-cell mass and function in diabetic db/db mice. Male db/db mice were divided into two groups with or without...
8.
Kimura T, Kaneto H, Shimoda M, Hirukawa H, Okauchi S, Kohara K, et al.
Mol Cell Endocrinol
. 2014 Dec;
400:78-89.
PMID: 25463759
The aim was to compare the protective effects of pioglitazone (PIO) and/or liraglutide (LIRA) on β-cells with the progression of diabetes. Male db/db mice were treated with PIO and/or LIRA...
9.
Hashiramoto M, Kaku K
J Diabetes Investig
. 2014 May;
4(1):34-6.
PMID: 24843626
No abstract available.
10.
Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, et al.
J Diabetes Investig
. 2014 May;
3(1):39-40.
PMID: 24843544
No abstract available.